Safety of Eribulin plus Trastuzumab in pre-treated HER2-positive advanced breast cancer (ABC) patients: results from an Italian observational study

Laura Orlando, Saverio Cinieri, Giovanna Giordano et al.|Annals of Oncology|2016

Cited by 0